Tobacco causes the death of one person in the UK every five minutes, according to a new analysis by CR_UK Smoking rates have reduced in recent years but it remains the UK’s biggest cause of cancer and death
CRUK said the current death rate, based on almost 125,000 tobacco-attributable deaths in the UK of all ages in 2019, is “shocking”.
“Enough is enough and we’re calling on our supporters to join us in signing a petition that we’ll present to the Prime Minister urging him to take bold and decisive action to achieve a smokefree UK.”
Belgique Dernières Nouvelles, Belgique Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Obesity-related cancers take a toll in Southern Africa: Study reveals alarming trendsResearch analyzes the prevalence and mortality rates of obesity-related cancers in 16 Southern African countries. It identifies leukemia, esophageal cancer, and colon/rectum cancer as leading causes of cancer mortality in males, and breast cancer, leukemia, and esophageal cancer in females.
Lire la suite »
Vaping is the revenge of tobacco industry, says Micheál MartinMicheál Martin describes vaping as 'very dangerous, particularly for young people' as a new law to limit sales and advertising in Ireland is finalised vapes
Lire la suite »
Eliminating gene SRC-3 in immune cells triggers effective long-lasting anti-cancer responseResearchers at Baylor College of Medicine have discovered a crucial regulator of the anti-cancer immune response that could change the game in the fight against cancer. Published in the Proceedings of the National Academy of Sciences, the study shows that in animal models of breast and prostate cancer, eliminating the gene SRC-3, specifically in a type of immune cell called regulatory T cells (Tregs), triggered a lifelong anti-cancer response that eradicated the tumor without the typical side effects observed with other therapies.
Lire la suite »
TREM2 Acts as a Tumor Suppressor in Colorectal Carcinoma through Wnt1/β-catenin and Erk SignalingTREM2 (triggering receptor expressed on myeloid cells) is involved in the development of malignancies. However, the function of TREM2 in colorectal cancer has not been clearly elucidated. Here, we investigated TREM2 function for the first time in colorectal epithelial cancer cells and demonstrated that TREM2 is a novel tumor suppressor in colorectal carcinoma. Blockade of TREM2 significantly promoted the proliferation of HT29 colorectal carcinoma cells by regulating cell cycle-related factors, such as p53 phosphorylation and p21 and cyclin D1 protein levels. HT29 cell migration was also increased by TREM2 inhibition via MMP9 (matrix metalloproteinase 9) expression upregulation. Furthermore, we found that the tumor suppressor effects of TREM2 were associated with Wnt/β-catenin and extracellular signal-regulated kinase (ERK) signaling. Importantly, the effect of TREM2 in the suppression of tumor development was demonstrated by in vivo and in vitro assays, as well as in human colon cancer patient tissue arrays. Overall, our results identify TREM2 as a potential prognostic biomarker and therapeutic target for colorectal cancer.
Lire la suite »
Cycling Granny Mave completes 1,000-mile Scotland challengeGranny Mave raises £56,000 for cancer support on a challenge in memory of her three children.
Lire la suite »